As the investigation revealed, between January and March 2020, one of the suspects, who was in France, allegedly organised the dispatch of parcels containing concealed tablets to Moldova. The plan was subsequently to distribute the drugs throughout the country.
The consignments were transported by a company specialising in passenger and parcel services on the Paris–Chișinău route. Upon arrival in the country, the parcels were to be handed over to a second participant in the scheme. He was responsible for receiving them and distributing them further.
Law enforcement officers documented one such incident on 4 March 2020. They discovered 84 prohibited tablets in a parcel sent from France. These had been concealed amongst clothing and other goods, divided into 12 packages.
The parcel was delivered under the supervision of the law enforcement agencies. It was then transported from Chișinău to Bălți, where the second defendant was due to collect it. When the man arrived to collect the parcel, he was arrested.
During the investigation, both defendants denied their guilt. One claimed that the drugs were intended for personal use. The other, however, stated that he had no involvement whatsoever in the dispatch or receipt of the parcels.
The trial took place in the absence of the defendants, as both were wanted by the police. Having examined the evidence presented, the court found the men guilty.
One of them was sentenced to eight years’ imprisonment for the illegal distribution of psychotropic substances on a particularly large scale. The other received a 10-year prison sentence.
Both convicted men will serve their sentences in a closed prison. In addition, they have been barred from holding certain positions.
This story was translated with the assistance of artificial intelligence.The translation was also reviewed by the Logos Press editorial team.
Follow our updates
Have information for the newsroom? Share it with Logos-Press
Comments
0No comments yet. You can start the conversation.
Comments are open to readers with a Logos Press account.
Sign in to comment